---
figid: PMC8319838__cdr-4-17.fig.3
figtitle: Temozolomide resistance in glioblastoma - a comprehensive review
organisms:
- NA
pmcid: PMC8319838
filename: cdr-4-17.fig.3.jpg
figlink: /pmc/articles/PMC8319838/figure/fig3/
number: F3
caption: 'Molecular pathways associated with TMZ resistance. In the RTK pathway, activation
  of RTK results in downstream signaling controlling cell survival or apoptosis. Amplification
  of EGFR and inclusion of the mutant variant EGFRvIII, both RTKs, occurs in a majority
  of GBM. EGFRvIII has been shown to be a constitutively active mutant of EGFR, with
  ligand-independent activation resulting in RTK/RAS/PI3 dysregulation. Modified from
  Pearson et al.[]. TMZ: temozolomide; RTKs: receptor tyrosine kinases; EGFR: epidermal
  growth factor receptor; EGFRvIII: epidermal growth factor receptor variant III'
papertitle: Mechanisms of temozolomide resistance in glioblastoma - a comprehensive
  review.
reftext: Neha Singh, et al. Cancer Drug Resist. 2021;4(1):17-43.
year: '2021'
doi: 10.20517/cdr.2020.79
journal_title: Cancer Drug Resistance
journal_nlm_ta: Cancer Drug Resist
publisher_name: OAE Publishing Inc.
keywords: Glioblastoma | temozolomide | chemoresistance | molecular mechanisms
automl_pathway: 0.9187582
figid_alias: PMC8319838__F3
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC8319838__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8319838__cdr-4-17.fig.3.html
  '@type': Dataset
  description: 'Molecular pathways associated with TMZ resistance. In the RTK pathway,
    activation of RTK results in downstream signaling controlling cell survival or
    apoptosis. Amplification of EGFR and inclusion of the mutant variant EGFRvIII,
    both RTKs, occurs in a majority of GBM. EGFRvIII has been shown to be a constitutively
    active mutant of EGFR, with ligand-independent activation resulting in RTK/RAS/PI3
    dysregulation. Modified from Pearson et al.[]. TMZ: temozolomide; RTKs: receptor
    tyrosine kinases; EGFR: epidermal growth factor receptor; EGFRvIII: epidermal
    growth factor receptor variant III'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pten
  - Dif
  - dl
  - Rel
  - cass
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Pdk
  - Pdk1
  - sgg
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Egfr
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - foxo
  - norpA
  - sl
  - Plc21C
  - Tie
  - Ras85D
  - InR
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - Sos
  - grb
  - Mtor
  - Tor
  - sima
  - CycE
  - cyc
  - ras
  - Ras64B
  - Raf
  - Dsor1
  - Mtk
  - PTEN
  - NFKB1
  - BAD
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - GSK3A
  - GSK3B
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - EGFR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - EGF
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - XYLT2
  - SOS1
  - SOS2
  - MTOR
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
---
